Literature DB >> 10508163

A novel peptide-SH3 interaction.

A M Mongioví1, P R Romano, S Panni, M Mendoza, W T Wong, A Musacchio, G Cesareni, P P Di Fiore.   

Abstract

SH3 domains constitute a family of protein-protein interaction modules that bind to peptides displaying an X-proline-X-X-proline (XPXXP) consensus. We report that the SH3 domain of Eps8, a substrate of receptor and non-receptor tyrosine kinases, displays a novel and unique binding preference. By a combination of approaches including (i) screening of phage-displayed random peptide libraries, (ii) mapping of the binding regions on three physiological interactors of Eps8, (iii) alanine scanning of binding peptides and (iv) in vitro cross-linking, we demonstrate that a proline-X-X-aspartate-tyrosine (PXXDY) consensus is indispensable for binding to the SH3 domain of Eps8. Screening of the Expressed Sequence Tags database allowed the identification of three Eps8-related genes, whose SH3s also display unusual binding preferences and constitute a phylogenetically distinct subfamily within the SH3 family. Thus, Eps8 identifies a novel family of SH3-containing proteins that do not bind to canonical XPXXP-containing peptides, and that establish distinct interactions in the signaling network.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508163      PMCID: PMC1171600          DOI: 10.1093/emboj/18.19.5300

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

1.  The peroxisomal membrane protein Pex13p shows a novel mode of SH3 interaction.

Authors:  P Barnett; G Bottger; A T Klein; H F Tabak; B Distel
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

2.  Intersectin 1L guanine nucleotide exchange activity is regulated by adjacent src homology 3 domains that are also involved in endocytosis.

Authors:  Jennifer L Zamanian; Regis B Kelly
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

3.  Recognition of tandem PxxP motifs as a unique Src homology 3-binding mode triggers pathogen-driven actin assembly.

Authors:  Olli Aitio; Maarit Hellman; Arunas Kazlauskas; Didier F Vingadassalom; John M Leong; Kalle Saksela; Perttu Permi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 4.  Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction.

Authors:  Shawn S-C Li
Journal:  Biochem J       Date:  2005-09-15       Impact factor: 3.857

5.  Ubiquitin binds to and regulates a subset of SH3 domains.

Authors:  Svetoslava D Stamenova; Michael E French; Yuan He; Smitha A Francis; Zachary B Kramer; Linda Hicke
Journal:  Mol Cell       Date:  2007-01-26       Impact factor: 17.970

6.  Structural insights into the recognition of β3 integrin cytoplasmic tail by the SH3 domain of Src kinase.

Authors:  Priya Katyal; Robbins Puthenveetil; Olga Vinogradova
Journal:  Protein Sci       Date:  2013-09-04       Impact factor: 6.725

Review 7.  SH3 domains: modules of protein-protein interactions.

Authors:  Natalya Kurochkina; Udayan Guha
Journal:  Biophys Rev       Date:  2012-06-20

8.  The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold.

Authors:  R Stoll; C Renner; M Zweckstetter; M Brüggert; D Ambrosius; S Palme; R A Engh; M Golob; I Breibach; R Buettner; W Voelter; T A Holak; A K Bosserhoff
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

9.  Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p.

Authors:  Keiichiro Kami; Ryu Takeya; Hideki Sumimoto; Daisuke Kohda
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

10.  The inositol 5-phosphatase SHIP2 regulates endocytic clathrin-coated pit dynamics.

Authors:  Fubito Nakatsu; Rushika M Perera; Louise Lucast; Roberto Zoncu; Jan Domin; Frank B Gertler; Derek Toomre; Pietro De Camilli
Journal:  J Cell Biol       Date:  2010-08-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.